| dbo:abstract
|
- "NeuroAiD" es un tratamiento oral de origen natural que se toma para recuperar después de un derrame cerebral. Originado de la medicina china tradicional (MCT), NeuroAiD fue desarrollado en China para ayudar a los pacientes a recuperar sus funciones neurológicas dañadas durante el ACV. Desde el 2006 una versión mejorada de NeuroAiD está siendo comercializada fuera de China por la empresa de biotecnología Moleac Pte Ltd destacada en Singapur. (es)
- NeuroAiD is a herbal supplement proposed to support functional recovery after strokes. There were two formulations of NeuroAiD: MLC601 (NeuroAiDTM) was first developed. Since 2018 MLC601 formulation is no longer on the market, and has been replaced by MLC901 (NeuroAiDTMII), a simplified formulation containing only 9 botanical ingredients. It can be administered orally or through a feeding tube. Research has found the drug to be of no benefit for aiding stroke recovery. Common side effects include abdominal discomfort, headaches, dry mouth, nausea, vomiting, and diarrhea. Though very rare, some patients have reported serious adverse events in clinical trials (jaundice, hypokalemia, seizures, and recurring strokes). NeuroAiD was first registered and marketed in China in 2001. It was patented in the United States in 2013, but has not been approved by the FDA. NeuroAiD is distributed by Moleac, and is derived from traditional Chinese medicine. According to the CEO of Moleac, NeuroAiD is sold in at least 25 countries, and 20,000 people have taken it. (en)
- NeuroAiD est un traitement naturel par voie orale indiqué dans la récupération post-AVC, encore appelé attaque cérébrale. Issu de la médecine traditionnelle chinoise (MTC), NeuroAiD a été développé en Chine pour aider les patients à récupérer leurs fonctions neurologiques endommagées lors de l'attaque cérébrale. Depuis 2006, Neuroaid est commercialisé hors de Chine sous une forme améliorée par la société biopharmaceutique Moleac Pte Ltd, basée à Singapour. (fr)
|
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 11222 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdfs:comment
|
- "NeuroAiD" es un tratamiento oral de origen natural que se toma para recuperar después de un derrame cerebral. Originado de la medicina china tradicional (MCT), NeuroAiD fue desarrollado en China para ayudar a los pacientes a recuperar sus funciones neurológicas dañadas durante el ACV. Desde el 2006 una versión mejorada de NeuroAiD está siendo comercializada fuera de China por la empresa de biotecnología Moleac Pte Ltd destacada en Singapur. (es)
- NeuroAiD est un traitement naturel par voie orale indiqué dans la récupération post-AVC, encore appelé attaque cérébrale. Issu de la médecine traditionnelle chinoise (MTC), NeuroAiD a été développé en Chine pour aider les patients à récupérer leurs fonctions neurologiques endommagées lors de l'attaque cérébrale. Depuis 2006, Neuroaid est commercialisé hors de Chine sous une forme améliorée par la société biopharmaceutique Moleac Pte Ltd, basée à Singapour. (fr)
- NeuroAiD is a herbal supplement proposed to support functional recovery after strokes. There were two formulations of NeuroAiD: MLC601 (NeuroAiDTM) was first developed. Since 2018 MLC601 formulation is no longer on the market, and has been replaced by MLC901 (NeuroAiDTMII), a simplified formulation containing only 9 botanical ingredients. It can be administered orally or through a feeding tube. Research has found the drug to be of no benefit for aiding stroke recovery. (en)
|
| rdfs:label
|
- Neuroaid (es)
- Neuroaid (fr)
- NeuroAiD (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
